Effects of varenicline on the serum levels of olanzapine in male patients with Schizophrenia: a randomized controlled trial

BACKGROUND: Smoking in patients with Schizophrenia is more common than in the general population. Varenicline, a partial agonist at α4β2 nicotinic acetylcholine receptors, is an effective smoking cessation pharmacotherapy in patients with Schizophrenia. However, its effects on the serum levels of an...

Descripción completa

Detalles Bibliográficos
Autores principales: Deng, Mengling, Yang, Zhi, Ni, Yanfei, Zhu, Lingli, Xu, Jiating, Zheng, Lifeng, Zhou, Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235537/
https://www.ncbi.nlm.nih.gov/pubmed/37275966
http://dx.doi.org/10.3389/fpsyt.2023.1142419

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10235537/
https://www.ncbi.nlm.nih.gov/pubmed/37275966
http://dx.doi.org/10.3389/fpsyt.2023.1142419

Ejemplares similares